Shares of Quidel Corporation (NASDAQ:QDEL) have earned a consensus rating of “Hold” from the nine brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $34.00.

Several research firms recently issued reports on QDEL. Zacks Investment Research cut Quidel Corporation from a “buy” rating to a “hold” rating in a research report on Friday, July 21st. TheStreet cut Quidel Corporation from a “b-” rating to a “c” rating in a research report on Wednesday, July 26th. Raymond James Financial, Inc. increased their target price on Quidel Corporation from $36.00 to $41.00 and gave the stock an “outperform” rating in a research report on Thursday, July 27th. Barclays PLC increased their target price on Quidel Corporation from $36.00 to $39.00 and gave the stock an “overweight” rating in a research report on Thursday, July 27th. Finally, William Blair upgraded Quidel Corporation from a “market perform” rating to an “outperform” rating in a research report on Tuesday, July 18th.

COPYRIGHT VIOLATION NOTICE: “Quidel Corporation (QDEL) Receives Average Recommendation of “Hold” from Analysts” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/09/01/quidel-corporation-qdel-receives-average-recommendation-of-hold-from-analysts.html.

Shares of Quidel Corporation (NASDAQ:QDEL) traded up 0.98% during mid-day trading on Friday, hitting $34.94. The stock had a trading volume of 185,971 shares. The stock’s 50-day moving average is $33.62 and its 200 day moving average is $26.36. The company’s market cap is $1.17 billion. Quidel Corporation has a 12 month low of $18.25 and a 12 month high of $38.92.

Quidel Corporation (NASDAQ:QDEL) last released its earnings results on Wednesday, July 26th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.18. Quidel Corporation had a negative return on equity of 0.03% and a negative net margin of 0.03%. The business had revenue of $38.30 million for the quarter, compared to analysts’ expectations of $41.91 million. During the same quarter in the prior year, the business posted ($0.11) EPS. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. On average, equities research analysts forecast that Quidel Corporation will post $0.28 earnings per share for the current fiscal year.

In other Quidel Corporation news, CFO Randall J. Steward sold 94,215 shares of the firm’s stock in a transaction that occurred on Friday, July 28th. The stock was sold at an average price of $34.09, for a total transaction of $3,211,789.35. Following the completion of the transaction, the chief financial officer now owns 79,907 shares in the company, valued at approximately $2,724,029.63. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Douglas C. Bryant sold 36,000 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $33.83, for a total value of $1,217,880.00. Following the transaction, the chief executive officer now owns 296,493 shares of the company’s stock, valued at approximately $10,030,358.19. The disclosure for this sale can be found here. Insiders have sold a total of 167,388 shares of company stock valued at $5,452,152 in the last 90 days. 22.00% of the stock is currently owned by company insiders.

Several large investors have recently bought and sold shares of QDEL. Point72 Asset Management L.P. bought a new stake in Quidel Corporation during the first quarter valued at about $11,266,000. Macquarie Group Ltd. raised its stake in Quidel Corporation by 23.6% in the first quarter. Macquarie Group Ltd. now owns 1,195,927 shares of the company’s stock valued at $27,076,000 after buying an additional 228,515 shares during the last quarter. Chicago Equity Partners LLC bought a new stake in Quidel Corporation during the second quarter valued at about $5,062,000. Marshall Wace North America L.P. raised its stake in Quidel Corporation by 370.1% in the second quarter. Marshall Wace North America L.P. now owns 171,800 shares of the company’s stock valued at $4,639,000 after buying an additional 135,253 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in Quidel Corporation by 27.6% in the second quarter. Renaissance Technologies LLC now owns 612,487 shares of the company’s stock valued at $16,623,000 after buying an additional 132,587 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

About Quidel Corporation

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Analyst Recommendations for Quidel Corporation (NASDAQ:QDEL)

Receive News & Stock Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related stocks with our FREE daily email newsletter.